Disease | hematologic cancer |
Phenotype | C0026764|multiple myeloma |
Sentences | 2 |
PubMedID- 24249729 | Melphalan (mel) is widely used to treat patients with hematologic cancer, including multiple myeloma, but its mechanism of action in ebv-transformed b cells is poorly described. |
PubMedID- 23289028 | multiple myeloma accounts for 10% of all hematologic cancers. |
Page: 1